BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 809834)

  • 1. Immunochemical studies on free and bound J chain of human IgA and IgM.
    Brandtzaeg P
    Scand J Immunol; 1975 Sep; 4(5-6):439-50. PubMed ID: 809834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of intracellular J-chain and binding site for secretory component (SC) in human immunoglobulin (Ig)-producing cells.
    Brandtzaeg P
    Mol Immunol; 1983 Sep; 20(9):941-66. PubMed ID: 6417474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of J chain in human biological fluids by a simple immunochemical procedure.
    Grubb AO
    Acta Med Scand; 1978; 204(6):453-65. PubMed ID: 104551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex formation between secretory component and human immunoglobulins related to their content of J chain.
    Brandtzaeg P
    Scand J Immunol; 1976; 5(4):411-9. PubMed ID: 821140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of J chain after mild reduction of human immunoglobulins.
    Brandtzaeg P
    Scand J Immunol; 1975; 4(4):309-20. PubMed ID: 810882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of J-chain from bovine colostral immunoglobulin M.
    Komar R; Mukkur TK
    Can J Biochem; 1975 Sep; 53(9):943-9. PubMed ID: 810233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the association of human secretory component with IgA and IgM proteins.
    Weicker J; Underdown BJ
    J Immunol; 1975 Apr; 114(4):1337-44. PubMed ID: 1167881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for incorporation of J chain into human IgM and IgA.
    Sørensen V; Rasmussen IB; Sundvold V; Michaelsen TE; Sandlie I
    Int Immunol; 2000 Jan; 12(1):19-27. PubMed ID: 10607746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the J chain from polymeric immunoglobulins (IgA-IgM-immunological specificity-primary structure).
    Morrison SL; Koshland ME
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):124-8. PubMed ID: 4109595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking effect of J chain and J-chain antibody on the binding of secretory component to human IgA and IgM.
    Brandtzaeg P
    Scand J Immunol; 1975; 4(8):837-42. PubMed ID: 814614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody against the human J chain inhibits polymeric Ig receptor-mediated biliary and epithelial transport of human polymeric IgA.
    Vaerman JP; Langendries AE; Giffroy DA; Kaetzel CS; Fiani CM; Moro I; Brandtzaeg P; Kobayashi K
    Eur J Immunol; 1998 Jan; 28(1):171-82. PubMed ID: 9485197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM molecules with and without J chain in serum and after purification, studied by ultracentrifugation, electrophoresis, and electron microscopy.
    Eskeland T; Christensen TB
    Scand J Immunol; 1975; 4(3):217-28. PubMed ID: 807966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous regulation of VH and CH allotypes among Ig molecules in multi-heterozygous rabbits suppressed with anti-VH allotype antibody: emergence of IgA from suppression prior to IgG and IgM.
    Eskinazi DP; Gilman-Sachs A; Knight KL; Dray S
    J Immunol; 1976 Jul; 117(1):124-9. PubMed ID: 819578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of different J chain profiles in human tissues: generation of IgA and IgM with binding site for secretory component is related to the J chain expressing capacity of the total local immunocyte population, including IgG and IgD producing cells, and depends on the clinical state of the tissue.
    Brandtzaeg P; Korsrud FR
    Clin Exp Immunol; 1984 Dec; 58(3):709-18. PubMed ID: 6439452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D Structures of IgA, IgM, and Components.
    Pan S; Manabe N; Yamaguchi Y
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of IgA myeloma proteins isolated rom sera of patients with the hyperviscosity syndrome.
    Mestecky J; Hammack WJ; Kulhavy R; Wright GP; Tomana M
    J Lab Clin Med; 1977 May; 89(5):919-27. PubMed ID: 404374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carboxyl-terminal domains of IgA and IgM direct isotype-specific polymerization and interaction with the polymeric immunoglobulin receptor.
    Braathen R; Sorensen V; Brandtzaeg P; Sandlie I; Johansen FE
    J Biol Chem; 2002 Nov; 277(45):42755-62. PubMed ID: 12213814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nature of the polymeric serum IgA in man.
    Radl J; Swart AC; Mestecky J
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):482-4. PubMed ID: 813236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesangial deposition of J chain-linked polymeric IgA in IgA nephropathy.
    Komatsu N; Nagura H; Watanabe K; Nomoto Y; Kobayashi K
    Nephron; 1983; 33(1):61-4. PubMed ID: 6403880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis of immunoglobulin A (IgA) and immunoglobulin M (IgM). Control of polymerization by J chain.
    Parkhouse RM; Della Corte E
    Biochem J; 1973 Nov; 136(3):607-9. PubMed ID: 4205353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.